InvestorsHub Logo
Followers 121
Posts 2776
Boards Moderated 1
Alias Born 02/09/2004

Re: SSKILLZ1 post# 113249

Friday, 05/24/2024 11:53:43 AM

Friday, May 24, 2024 11:53:43 AM

Post# of 118267
I still really like INDV. For those that are interested, here is their investor day presentation (very detailed):
https://www.indivior.com/resources/dam/id/1358/Analyst%20Teach%20In%20Presentation%20VersionvF.pdf

The key for them in the intermediate term is getting more patients on their proprietary Sublocade drug, which is injectable and longer lasting than its other offering Suboxone, which competes against generics and is meant for daily, self-administered use. The quick pitch is that Sublocade is more effective as a treatment for opioid addiction since it's not needed daily and it has shown higher effectiveness at keeping people from relapsing. (I wonder if they would consider using HALO as a way of administering it?). Its also far easier to administer to people who are in prison, since its not a daily dose. A lot of their customers/patients have been incarcerated or are on the fringes of society. Addiction (esp opioid) is one of the few issues today that has bipartisan support in terms of finding the funding to help those in need of assistance with effective treatment.

One of the interesting things about this 6K filer is that they file all transactions in their own shares (repurchases) on a daily basis. Wish that this were the case for 8K filers! They are planning on making the US listing their primary listing very soon. They got approval from the shareholders to do this and so were in the US yesterday pitching their story to US investors/analysts.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.